Phase 2 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with colorectal cancer (cancer of the colon or rectum) confirmed by a tissue biopsy.
- People whose cancer has spread to the liver in a way that cannot be removed by surgery.
- People whose scans (PET/CT) taken within 4 weeks before the transplant team meeting show no signs of cancer spread outside the liver — although having 1 to 3 small removable spots on the lungs (all smaller than 15mm) may still be acceptable.
- People whose CT scans of the chest, abdomen, and pelvis taken within 4 weeks before the transplant team meeting show no signs of cancer spread outside the liver — again, 1 to 3 small removable lung spots may still be acceptable.
- People with rectal cancer who have had an MRI of the pelvis within 4 weeks before the transplant team meeting showing no sign of the cancer returning in the pelvis.
- People who have had a bowel examination (colonoscopy or CT scan of the bowel) within 12 months before the transplant team meeting showing no sign of the cancer returning locally.
- People who are in good general health and able to carry out everyday activities with little or no limitation (confirmed with trial site).
- People whose blood test results meet required levels for red blood cells, white blood cells, platelets, liver function, kidney function, and protein levels (confirm specific values with trial site).
- People who have given written consent and are willing and able to attend treatment and follow-up appointments as required.
- People who have already received at least 8 weeks of chemotherapy.
Who may not be able to join:
- People who have lost more than 10% of their body weight in the past 6 months.
- People with a Body Mass Index (BMI) over 30 (a commonly used measure of body weight relative to height).
- People who have previously been diagnosed with cancer that has spread to the bones or brain/nervous system.
- People who have previously been diagnosed with breast cancer or melanoma (a type of skin cancer).
- People who have had surgery to remove part of their bowel cancer for comfort or symptom relief rather than with the intent to cure.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 23026600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent of transplanted patients receiving second stage hepatectomy within 4 weeks of segment 2/3 transplantation.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.